摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(6S,8S,9S,10S,1'S)-5-methyl-8-(1'-ethyl-oxomethyl)-9-(1',3'-dioxolan-2'-yl)-12-benzyl-6,7,8,9,10,11-hexahydro-6,10-imino-5H-cyclooct[b]-indole | 143065-03-6

中文名称
——
中文别名
——
英文名称
(6S,8S,9S,10S,1'S)-5-methyl-8-(1'-ethyl-oxomethyl)-9-(1',3'-dioxolan-2'-yl)-12-benzyl-6,7,8,9,10,11-hexahydro-6,10-imino-5H-cyclooct[b]-indole
英文别名
(2S)-2-[(1S,12S,13S,14S)-16-benzyl-13-(1,3-dioxolan-2-yl)-3-methyl-3,16-diazatetracyclo[10.3.1.02,10.04,9]hexadeca-2(10),4,6,8-tetraen-14-yl]butanal
(6S,8S,9S,10S,1'S)-5-methyl-8-(1'-ethyl-oxomethyl)-9-(1',3'-dioxolan-2'-yl)-12-benzyl-6,7,8,9,10,11-hexahydro-6,10-imino-5H-cyclooct[b]-indole化学式
CAS
143065-03-6
化学式
C29H34N2O3
mdl
——
分子量
458.601
InChiKey
GVZCVOKNLHLPTI-QFTDFRCPSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.2
  • 重原子数:
    34
  • 可旋转键数:
    6
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.48
  • 拓扑面积:
    43.7
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • General approach for the synthesis of ajmaline-related alkaloids. Enantiospecific total synthesis of (-)-suaveoline, (-)-raumacline, and (-)-Nb-methylraumacline
    作者:Xiaoyong Fu、James M. Cook
    DOI:10.1021/jo00055a019
    日期:1993.1
    (-)-Raumacline (3) and (-)-Nb-methylraumacline (4), isolated from plant cell cultures of Rauwolfia serpentina Benth., have been synthesized from D-(+)-tryptophan in enantiospecific fashion. In addition, (-)-suaveoline (1) has also been prepared via this strategy. The synthesis of these indole alkaloids employed a stereospecific Pictet-Spengler/Dieckmann protocol to prepare the key intermediate, (-)-N(b)-benzyltetracyclic ketone 12. This ketone 12 was converted into the C-15 functionalized system 16 via an anionic oxy-Cope rearrangement; 16 had also been obtained by 1,4-addition of a Grignard reagent to the alpha,beta-unsaturated aldehyde (-)-8 generated from (-)-12. Conversion of 16 into either (-)-N(b)-benzylsuaveoline (23) or (-)-N(b)-benzylraumacline (28), respectively, is described. Catalytic debenzylation of the hydrochloride salts of 23 and 28 in ethanol provided the corresponding alkaloids (-)-1 and (-)-3 in excellent yield. In contrast to the published reports, the optical rotation of (-)-suaveoline (>98% ee) was found to be [alpha]25D = -9.3-degrees (c = 0.30, CHCl3) rather than 0-degrees as previously reported. Treatment of 23 or 28 (individually) with excess Pd/C and hydrogen in methanol yielded (-)-N(b)-methylsuaveoline and (-)-N(b)-methylraumacline in excellent yield, respectively.
    本研究成功地通过不对称方式利用D-(+)-色氨酸合成了从Rauwolfia serpentina Benth.植物细胞培养物中分离出的(-)-Raumacline(3)和(-)-Nb-甲基raumacline(4)。此外,(-)-Suaveoline(1)也通过该方法成功制备。在吲哚类生物碱的合成过程中,采用了一种立体特异的Pictet-Spengler/Dieckmann协议来制备关键中间体(-)-N(b)-苄基四环酮(12)。随后,通过阴离子氧-Cope重排,将酮12转化为C-15功能化系统16;另外,通过将Grignard试剂与从(-)-12生成的α,β-不饱和醛(-)-8进行1,4-加成,也获得了16。将16分别转化为(-)-N(b)-苄基suaveoline(23)或(-)-N(b)-苄基raumacline(28)的过程得到了详细描述。通过在乙醇中使用乙醇的催化脱苄基反应,分别以优异的产率得到了相应的生物碱(-)-1和(-)-3。与已发布的报告不同,(-)-Suaveoline的光学旋转被发现为[α]D25 = -9.3度(c = 0.30,CHCl3),而不是先前报告的0度。将23或28分别与过量的Pd/C和氢气在甲醇中处理,分别以优异的产率得到了(-)-N(b)-甲基suaveoline和(-)-N(b)-甲基raumacline。
  • Enantiospecific Total Synthesis of (−)-(<i>E</i>)16-Epiaffinisine, (+)-(<i>E</i>)16-Epinormacusine B, and (+)-Dehydro-16-epiaffinisine as well as the Stereocontrolled Total Synthesis of Alkaloid G
    作者:Jianming Yu、Tao Wang、Xiangyu Z. Wearing、Jun Ma、James M. Cook
    DOI:10.1021/jo030116o
    日期:2003.7.1
    An efficient strategy is described for the total synthesis of the sarpagine-related indole alkaloids (-)-(E)16-epiaffinisine (1), (+)-(E)16-epinormacusine B (2), and (+)-dehydro-16-epiaffinisine (4). A key step employed the chemospecific and regiospecific hydroboration/oxidation at C(16)-C(17); this method has also resulted in the synthesis of (+)-dehydro-16-epinormacusine B (5). The oxy-anion Cope
    一种有效的策略描述了总的合成与沙雷帕因相关的吲哚生物碱(-)-(E)16-epiaffinisine(1),(+)-(E)16-epinormacusine B(2)和(+)-脱氢16-表阿帕尼星(4)。关键步骤是在C(16)-C(17)上进行化学特异性和区域特异性氢硼化/氧化;这种方法还导致了(+)-dehydro-16-epinormacusine B的合成(5)。在动力学控制条件下产生的氧负离子Cope重排,然后进行烯醇化,已被用于在生物碱G(7)中的C(15),C(16)和C(20)处生成关键的不对称中心。以高度立体声控制的方式(> 43:1)。确定了有利于控制C(16)上的沙雷帕汀立体化学相对于相同立体中心的差向异构体阿玛琳构型的条件。
  • General Approach to the Synthesis of Sarpagine and Ajmaline Alkaloids. Enantiospecific Total Synthesis of (+)-Ajmaline and Alkaloid G via the Asymmetric Pictet−Spengler Reaction
    作者:Jin Li、James M. Cook
    DOI:10.1021/jo980476p
    日期:1998.6.1
  • Enantiospecific total synthesis of the ajmaline related alkaloids (-)-suaveoline, (-)-raumacline, and (-)-Nb-methylraumacline
    作者:Xiaoyong Fu、James M. Cook
    DOI:10.1021/ja00043a043
    日期:1992.8
  • General Approach for the Synthesis of Ajmaline/Sarpagine Indole Alkaloids:  Enantiospecific Total Synthesis of (+)-Ajmaline, Alkaloid G, and Norsuaveoline via the Asymmetric Pictet−Spengler Reaction
    作者:Jin Li、Tao Wang、Peng Yu、A. Peterson、R. Weber、D. Soerens、D. Grubisha、D. Bennett、J. M. Cook
    DOI:10.1021/ja990184l
    日期:1999.8.1
    enantiospecific fashion via the asymmetric Pictet−Spengler reaction and a stereocontrolled oxyanion-Cope rearrangement as key steps. The synthesis of these indole alkaloids employed a stereospecific Pictet−Spengler/Dieckmann protocol to prepare the key intermediate, (−)-Nb-benzyl tetracyclic ketone (7a or 7b). This ketone was converted into α,β-unsaturated aldehyde (8a or 8b) and further transformed into (+)-ajmaline
    已开发出合成沙巴胺/阿玛林吲哚生物碱的一般方法(氧阴离子-Cope 策略)。(+)-Ajmaline 1 和生物碱 G 2 以及norsuaveoline 3 已通过不对称 Pictet-Spengler 反应和立体控制的氧阴离子-Cope 重排以对映特异性方式从 d-(+)-色氨酸合成为关键步骤。这些吲哚生物碱的合成采用立体特异性 Pictet-Spengler/Dieckmann 方案来制备关键中间体,(-)-Nb-苄基四环酮(7a 或 7b)。该酮转化为 α,β-不饱和醛(8a 或 8b),并进一步转化为 (+)-ajmaline 1 和生物碱 G 2 以及norsuaveoline 3。还发现可以立体特异性地还原 29 以形成 2-表二乙酰基基马林衍生物 30,其在 C(2) 处具有与 quebrachidine 和双吲哚 alstonisidine 相同的构型。形成 sarpagine
查看更多

同类化合物

马枯素C 钩吻素戊 萨杷晋碱 维洛斯明碱 洛柯碱 妥包嗪 大斯配加春 双斯配加春 佩西立文 二氢派利文碱 [(1S,12S,14R,15E)-15-亚乙基-3-甲基-3,17-二氮杂环[12.3.1.02,10.04,9.012,17]十八碳-2(10),4,6,8-四烯-13-基]甲醇 16-表萨杷晋碱 11-甲氧基马枯素A (+)-阿枯米定碱 alkaloid G (+)-affinisine (+)-Na-methyl-16-epipericyclivine trinervine alstoserine (-)-alkaloid Q3 (+)-dehydroepiaffinisine (2S,6S,12bS)-3-Eth-(E)-ylidene-12-methyl-13-methylene-1,3,4,7,12,12b-hexahydro-2H,6H-2,6-methano-indolo[2,3-a]quinolizine (2R,6S,12bS,13S)-3-Eth-(E)-ylidene-9-methoxy-12-methyl-1,3,4,7,12,12b-hexahydro-2H,6H-2,6-methano-indolo[2,3-a]quinolizine-13-carbaldehyde (+)-Na-methyl-10-methoxypericyclivine [(2R,6S,12bS,13S)-3-Eth-(E)-ylidene-9-methoxy-12-methyl-1,3,4,7,12,12b-hexahydro-2H,6H-2,6-methano-indolo[2,3-a]quinolizin-13-yl]-methanol normacusine B (6S,8S,9R,11R,11aS)-11-(1,3-dioxolan-2-yl)-8-methyl-5,6,8,9,10,11,11a,12-octahydro-6,10-methanoindolo[3,2-b]quinolizine-9-carboxaldehyde (6S,8S,11aS)-8-methyl-9-methylene-6,8,9,10,11a,12-hexahydro-6,10-methanoindolo[3,2-b]quinolizin-11(5H)-one (6S,8S,11R,11aS)-11-(1,3-dioxolan-2-yl)-8-methyl-9-methylene-5,6,8,9,10,11,11a,12-octahydro-6,10-methanoindolo[3,2-b]quinolizine ((6S,8S,9R,11R,11aS)-11-(1,3-dioxolan-2-yl)-8-methyl-5,6,8,9,10,11,11a,12-octahydro-6,10-methanoindolo[3,2-b]quinolizin-9-yl)methanol 19(S),20(R)-dihydroperaksine-17-al ((6S,8S,9S,11R,11aS)-11-(1,3-dioxolan-2-yl)-8-methyl-5,6,8,9,10,11,11a,12-octahydro-6,10-methanoindolo[3,2-b]-quinolizin-9-yl)methanol (-)-(6S,10S)-5-methyl-8-(1'-ethyl-2'-pentenyl)-12-benzyl-6,7,8,9,10,11-hexahydro-6,10-imino-5H-cyclooctindole-9-carboxaldehyde (-)-(6S,10S)-5-methyl-8-(1'-ethyl-2'-pentenyl)-12-benzyl-6,7,8,9,10,11-hexahydro-6,10-imino-5H-cyclooctindole-9-carboxaldehyde published koumidine koumidine Normacusin B Macusine C chloride Macusine B nitrate Macusine B iodide Macusine B Macusine B chloride hydrochloride Macusine A Macusine B chloride [(1S,12S,13R,14S,15E)-15-ethylidene-7-methoxy-3,17-diazapentacyclo[12.3.1.02,10.04,9.012,17]octadeca-2(10),4(9),5,7-tetraen-13-yl]methanol Verticillatine (Rauwolfia) epi-(+)-Na-methylvellosimine Na-Methylgardneral (+)-(E)-16-epiaffinisine voachalotinol